Market Value152,789,000
Total Holdings46
File Date2018-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NLTX / Neoleukin Therapeutics, Inc.
JD / JD.com, Inc. - Depositary Receipt (Common Stock)
MS / Morgan Stanley
US0153511094 / Alexion Pharmaceuticals, Inc.
ECYT / Endocyte, Inc.
LJPC / La Jolla Pharmaceutical Co.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
DRNA / Dicerna Pharmaceuticals Inc
DOVA / Dova Pharmaceuticals, Inc.
AWI / Armstrong World Industries, Inc.
KALA / KALA BIO, Inc.
/ Immunomedics, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
FOXA / Fox Corporation
SGEN / Seagen Inc
SLM / SLM Corporation
TRN / Trinity Industries, Inc.
C / Citigroup Inc.
TVTX / Travere Therapeutics, Inc.
CORI / Corium International, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
GBT / Global Blood Therapeutics Inc.
BMRN / BioMarin Pharmaceutical Inc.
TGTX / TG Therapeutics, Inc.
INCY / Incyte Corporation
BHVN / Biohaven Ltd.
HRTX / Heron Therapeutics, Inc.
FOLD / Amicus Therapeutics, Inc.
MYOV / Myovant Sciences Ltd
ACAD / ACADIA Pharmaceuticals Inc.
GHDX / Genomic Health, Inc.
ADS / Bread Financial Holdings Inc
WVE / Wave Life Sciences Ltd.
ZGNX / Zogenix Inc
STX / Seagate Technology Holdings plc
BRK.A / Berkshire Hathaway Inc.
AMZN / Amazon.com, Inc.
IFRX / InflaRx N.V.
ALNY / Alnylam Pharmaceuticals, Inc.
ABMD / Abiomed Inc.
BGNE / BeiGene, Ltd. - Depositary Receipt (Common Stock)
CBRE / CBRE Group, Inc.
SMLP / Summit Midstream Partners, LP - Limited Partnership
KKR / KKR & Co. Inc.
SLDB / Solid Biosciences Inc.
SAGE / Sage Therapeutics, Inc.
COCP / Cocrystal Pharma, Inc.
NBIX / Neurocrine Biosciences, Inc.
SPY / SPDR S&P 500 ETF
IOVA / Iovance Biotherapeutics, Inc.